Clinical Trial Update: Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of the fixed-dose combination of simvastatin and extended-release niacin (Simcor) for hypercholesterolemia has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Simcor (simvastatin / niacin extended-release)

Snippet

Sponsor: Kos Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED